SK

Santosh Kumar Singh

Active Director Director DIN 10712913
DIN 10712913 First appointment Jul 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Santosh Kumar Singh

Data last updated:

Santosh Kumar Singh is a Director at Biobizz Technology Private Limited (since 2024). The company operates in Healthcare.

DIN 10712913
Primary Designation Director
Industry Healthcare
First Appointment 20 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biobizz Technology Private Limited U62091DL2024PTC434340
Director20 Jul 20242024Active

Directorship timeline

Open interactive timeline →
Biobizz Technology Private Limited
Premium access

Shareholding and investment profile for Santosh Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Kumar Singh

Santosh Kumar Singh currently holds 1 directorship: Biobizz Technology Private Limited (Director, since 20 Jul 2024).

Santosh Kumar Singh was first appointed on 20 Jul 2024 as Director at Biobizz Technology Private Limited.

The current boards of Santosh Kumar Singh's companies include Bhagyashree Rahul Dhapodkar (Biobizz Technology Private Limited), Priyanka Devidas Kathane (Biobizz Technology Private Limited), Ranjeeta Jitendra Dewade (Biobizz Technology Private Limited), Shubham Singh (Biobizz Technology Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available